India's Nos1 Weekly For The Pharmaceutical Industry
|| About us || Feedback|| Advertising || Subscribe || Archives 

24th January 2002

[an error occurred while processing this directive]


Ofloxacin combo can cut down DOTS to 3 months: TRC study
THE international scientific community involved in tuberculosis research is highly excited over the findings of a new study published by the Chennai-based Tuberculosis Research Centre (TRC), which promises to cut down the current six-month DOTS regimen by half.


Micro Labs to enter Chinese, UK & US mkts
In an effort to penetrate into more sophisticated markets, the Bangalore-based Micro Labs has already reached final stages of negotiations with some of the front ranking companies in China, UK and the USA for formulations business.

Centre to restructure consent form to facilitate embryonic research
IDENTIFYING the potential of stem cell research in the country and to open the doors for full utilization of available embryos the Centre is incorporating the required stipulations in the consent form.

Edit Article

 The Marketing Programme: An Outline - A road map for pharma
companies preferring a rural ride

 Recession: An opportunity
or threat
-
Chalking out strategies for companies post recession
IT In Pharma
 CKM: Key to pharma
industry growth
Collaborative platform with common objects and services

Conversation
‘IPR protection will attract more FDI into the country’
Eli Lilly India, which grew 22 per cent in 2001, witnessed more than 70 per cent of its sales coming from insulin and anti-cancer products.

EXPRESS PHARMA PULSE
GLOBAL PHARMA
ICMR awards scientists for outstanding contribution
Anna Univ to induct more biotech courses
Stability Studies Quiz
Pharmacopeia, Eos boards cancel merger plans
Elan, AHP suspend Alzheimer’s vaccine studies

FDA panel rejects BMS pravastatin/aspirin combo

At a Glance
Schering-Plough may start waiting list for hepatitis drug
US trial to study mifepristone for cancer
Viagra may be subsidised in Australia
EDITORIAL
TECHNOLOGY TRENDZ

Editorial
Budget Musings
It’s about a month to go for Budget 2002 when the pharmaceutical industry must surely be waiting expectantly.
Edit Article
The Marketing Programme: An Outline
In the concluding part of the article, S Roy Choudhury suggests a road map for those pharma companies who would prefer a rural ride

Pfizer licenses SciQuest’s solution for research supply chain mgmt
Aventis, Cardinal win e-commerce awards
Oracle, PwC, Pharsight in drug devt pact
SAS to firm up in pharma, biotech
P&G donates drug dvpt technology to Mayo Clinic

CORPORATE

AstraZenaca, Avestha Gengraine to develop tuberculosis drug
Aurobindo shareholders okay 125 cr private placement
Morepen Labs Q3 net up by 11.6%
Caraco’s Dec ’01 sales to cross $1m

Untitled Document

Express Pharma Pulse
Global Pharma
IT in Pharma
Technology Trends
Corporate Monitor
Happennings
Editorial
Bulk Drug Prices Trends
Market Place 
Showcase

Scrips

Policies & Amendment

<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.